Poor Countries Fall Behind In Race To Reserve COVID-19 Vaccine
Wealthy countries have a strategy to secure doses of any forthcoming vaccines. And that's creating a problem for lower-income nations.
vaccine
Cuomo Says N.Y. Health Officials Will Review Any U.S.-Approved COVID-19 Vaccine
"The first question is, is the vaccine safe? Frankly, I'm not going to trust the federal government's opinion," Democratic Gov. Andrew Cuomo said at a news conference.
Army Marshals Resources To Aid In Race For Coronavirus Vaccine
The Army is working with private industry to create a coronavirus vaccine, but also working on its own. The military service has a history of creating vaccines and making medical breakthroughs.
'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns
Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.
Top Adviser To Operation Warp Speed Calls An October Vaccine 'Extremely Unlikely'
Dr. Moncef Slaoui, chief adviser to the administration's effort to develop a COVID-19 vaccine, said having a vaccine by next month was "not impossible." But a longer timetable appears more likely.
FDA Adviser: Not Realistic To Expect A COVID-19 Vaccine In 2020
Dr. Paul Offit, who serves on the Food and Drug Administration's vaccine advisory board, says he doesn't think an effective vaccine that's undergone adequate testing can be ready this year.
Fauci Says He's 'Optimistic' Americans Will Get Coronavirus Vaccine Next Year
Animal and human trials are promising, Dr. Anthony Fauci tells lawmakers Friday, and the government is preparing for widespread distribution once a vaccine is shown to be safe and effective.
UNC-Chapel Hill To Conduct COVID-19 Vaccine Trials
The University of North Carolina is among the new sites for a COVID-19 vaccine trial.
Poll Shows Only A Quarter Of African Americans Plan To Get Coronavirus Vaccine
A survey by The Associated Press-NORC Center for Public Affairs Research finds 25% of black respondents plan to get a COVID-19 vaccine when one becomes available, compared to 56% of whites.
In The Battle Against COVID-19, A Risk Of 'Vaccine Nationalism'
The race to defeat the coronavirus is generating competition among nations and multinational companies. The main competition appears to be between the United States and China.